Bicycle Therapeutics Statistics
NASDAQ: BCYCHealthcareBiotechnologyUSD
3.73-0.06 (-1.58%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Bicycle Therapeutics by the numbers
Bicycle Therapeutics has a market capitalization of $261.1 million based on 50.55M shares outstanding. With trailing EPS of $-2.68, Bicycle Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 5.7% below its 50-day average and 23.0% below its 200-day average.
Average daily trading volume is 389.74K shares, or about $1.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BCYC valuation vs. peer median
| Metric | BCYC | Peer median | Difference |
|---|---|---|---|
| Market cap | $261.07M | $266.37M | -2% |
| Avg. volume | 389.74K | 815.95K | -52% |
Peer median across 8 companies: SABS, IKT, LXEO, PALI, FATE, ACIU, VNDA, BBOT.
Valuation
- Market cap
- $261.07M
- EPS (TTM)
- $-2.68
- Shares outstanding
- 50.55M
Price and trading
- Previous close
- 3.79
- Open
- 3.75
- Day range
- 3.68 – 3.81
- 52-week range
- 3.33 – 9.16
- 52-week change
- -53.37%
- Beta
- —
- Volume
- 472.23K
- Average volume
- 389.74K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 29, 2026
Additional statistics
- Market Cap
- 261.07M
- Forward Pe
- -1.68
- Eps
- -2.68
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 9.16
- Week52 Low
- 3.33
- Avg Volume
- 389.74K
- Shares Outstanding
- 50.55M
- Ma50
- 3.95
- Ma200
- 4.84
- Earnings Date
- Oct 29, 2026
- Pct From52w High
- -59.28%
- Pct From52w Low
- 12.01%